Spinraza (nusinersen) Letter of Medical Necessity
Spinraza (nusinersen) PA requires genetic confirmation of SMA, functional baseline, and documentation of intrathecal administration plan.
FDA-Approved Indications
- ● spinal muscular atrophy (all types)
Why Spinraza Prior Authorization Gets Denied
The most common denial reasons across major payers:
- 1. Genetic confirmation missing
- 2. SMA type not documented
- 3. Functional assessment scores missing
What to Include in a Spinraza Letter of Medical Necessity
Document SMN1 deletion/mutation, SMA type, motor function scores (CHOP-INTEND, HFMSE), prior treatments, and the dosing plan.
Key clinical evidence to cite:
- ✓ ENDEAR, CHERISH, NURTURE, SHINE
Relevant guidelines:
- 📖 AAN SMA Guidelines
Spinraza Prior Authorization Criteria
Standard criteria across major US payers for Spinraza. Specific criteria vary by plan — RxCheckUp tailors each LMN to your patient's exact payer policy.
Typical step therapy requirements:
- → Documented failure or contraindication to formulary alternatives
Required documentation:
- ✓ ICD-10 diagnosis code with specificity
- ✓ Prior therapy history with dates, doses, and discontinuation reasons
- ✓ Specialist evaluation (where applicable)
- ✓ Baseline disease activity or biomarker results
- ✓ Clinical rationale citing FDA labeling or guidelines
Approval details:
Initial approval: typically 6 months. Renewal: 12 months with documented clinical response.
Payers Covering Spinraza
RxCheckUp tailors each LMN to the specific payer's medical policy and step therapy requirements:
Spinraza Prior Authorization FAQ
Why was my Spinraza prior authorization denied?
The most common denial reasons for Spinraza are: Genetic confirmation missing; SMA type not documented; Functional assessment scores missing.
What should a Spinraza Letter of Medical Necessity include?
Document SMN1 deletion/mutation, SMA type, motor function scores (CHOP-INTEND, HFMSE), prior treatments, and the dosing plan.
Which payers cover Spinraza?
Spinraza is covered by major US payers including UnitedHealthcare, Aetna, Cigna, BCBS, Medicare Part B, though formulary tier and prior authorization criteria vary.